0
Ethics in Practice   |    
The Ethics of Sham Surgery in Clinical Orthopaedic Research
Samir Mehta, MD1; Thomas G. Myers, MD2; Jess H. Lonner, MD3; G. Russell Huffman, MD, MPH4; Brian J. Sennett, MD4
1 Department of Orthopaedics and Sports Medicine, Harborview Medical Center, 325 9th Avenue, Box 359798, Seattle, WA 98104. E-mail address: samir.mehta@uphs.upenn.edu
2 Department of Orthopaedic Surgery, University of Pittsburgh, Kaufmann Medical Building, 3461 Fifth Avenue, Pittsburgh, PA 15213
3 Booth Bartolozzi Balderston Orthopaedics, Pennsylvania Hospital, 800 Spruce Street 3B Orthopaedics, Philadelphia, PA 19107
4 Division of Sports Medicine, Department of Orthopaedic Surgery, University of Pennsylvania, Penn Sports Medicine Center, Weightman Hall, 235 South 33rd Street, Philadelphia, PA 19104
The Journal of Bone & Joint Surgery.  2007; 89:1650-1653  doi:10.2106/JBJS.F.00563
5 Recommendations (Recommend) | 3 Comments | Saved by 3 Users Save Case

Extract

While other surgical specialties, such as neurosurgery and thoracic surgery, have already broached the ethical discussion surrounding sham surgery as a research method, published discussion regarding the use of the sham orthopaedic model has been limited1. One solution in orthopaedics would be to open up the debate and the decision-making process to the surgeons, as there is no current forum or body to do this2. An essential question in the debate on the ethics of sham surgery concerns resolving the tension between the highest standard of research design (the double-blind, randomized, placebo-controlled trial) and the highest standard of ethics (to do no harm to the patient)3.
Figures in this Article
    Sign In to Your Personal ProfileSign In To Access Full Content
    Not a Subscriber?
    Get online access for 30 days for $30
    New to JBJS?
    Sign up for a full subscription to both the print and online editions
    Register for a FREE limited account to get full access to all CME activities, to comment on public articles, or to sign up for alerts.
    Register for a FREE limited account to get full access to all CME activities
    Have a subscription to the print edition?
    Current subscribers to The Journal of Bone & Joint Surgery in either the print or quarterly DVD formats receive free online access to JBJS.org.
    Forgot your password?
    Enter your username and email address. We'll send you a reminder to the email address on record.

     
    Forgot your username or need assistance? Please contact customer service at subs@jbjs.org. If your access is provided
    by your institution, please contact you librarian or administrator for username and password information. Institutional
    administrators, to reset your institution's master username or password, please contact subs@jbjs.org
    Accreditation Statement
    These activities have been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of Orthopaedic Surgeons and The Journal of Bone and Joint Surgery, Inc. The American Academy of Orthopaedic Surgeons is accredited by the ACCME to provide continuing medical education for physicians.
    CME Activities Associated with This Article
    Submit a Comment
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discretion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe




    Samir Mehta, M.D.
    Posted on September 21, 2007
    Dr. Mehta responds to Dr. Means
    Hospital of the University of Pennsylvania, Philadelphia, PA

    Dr. Means' recommendations regarding the re-naming of "sham" surgery as "placebo" surgery is very appropriate. While we, as orthopaedic surgeons, may not want to admit it, our explanation of a condition or disease to a patient or the goals of surgery can bias a patient's decision. Even inclusion in a "sham" or "placebo" trial can give the patient a "therapeutic misconception."

    In addition to merely changing the terminology, physician-researchers should and will need to follow strict guidelines when embarking on such studies. "Placebo" surgery has a role in our profession as we move forward.

    Kenneth R Means, Jr., M.D.
    Posted on September 07, 2007
    Placebo Surgery Instead of Sham Surgery
    Curtis National Center, Union Memorial Hospital, Baltimore, MD

    To The Editor:

    I think we would all agree that Prospective Randomized Controlled Trials (PRCTs) are the best way for us to determine standards of care in the practice of evidence based medicine. The article by Mehta et al.(1) was an excellent review of the ethics involving, and need for, so called sham surgery. Perhaps one small way to decrease resistance to the concept of sham surgery would be a simple name change. I imagine that IRBs and our patients are reluctant to consider something with such a negative connotation as "sham".

    A PubMed(2) text search of "sham surgery" vs. "placebo surgery" reveals nearly 40 times as many results for the former (1277 vs. 33). Using "placebo surgery" instead, as Moseley et al.(3) did, may be helpful in allowing us, our patients, and the general public to more open-mindedly consider the option.

    The author did not receive any outside funding or grants in support of his research for or preparation of this work. Neither he nor a member of his immediate family received payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, division, center, clinical practice, or other charitable or nonprofit organization with which the author, or a member of his immediate family, is affiliated or associated .

    References:

    1. Samir Mehta, Thomas G. Myers, Jess H. Lonner, G. Russell Huffman, and Brian J. Sennett. The Ethics of Sham Surgery in Clinical Orthopaedic Research. J Bone Joint Surg Am 2007; 89: 1650-1653.

    2. http://www.ncbi.nlm.nih.gov/sites/entrez

    3. Moseley JB, O'Malley K, Petersen NJ, Menke TJ, Brody BA, Kuykendall DH, Hollingsworth JC, Ashton CM, Wray NP. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2002;347:81-88.

    Related Articles
    Related Cases
    Related Content
    Topic Collections
    Related Audio and Videos
    PubMed Articles
    The ethical hazards and programmatic challenges of genomic newborn screening.
    JAMA : the journal of the American Medical Association: Issue date- 2012 Feb 1
    Protecting research participants while reducing regulatory burdens.
    JAMA : the journal of the American Medical Association: Issue date- 2011 Nov 23
    Clinical Trials
    Readers of This Also Read...
    jbjs jobs
    12/22/2011
    ME - Central Maine Medical Center
    12/22/2011
    VA - Charleston Area Medical Center
    12/22/2011
    Maine - Central Maine Medical Center